Here are the sales results in Q1, Q2 and Q3 of 2019 about the 10 TOP Spine companies.We have also included 2 important spinal companies as Xtant Medical and Orthopediatrics. *In the chart, we have not included Medtronic which 2019 fiscal year ended last month of July , Stryker which Spinal sales are not published separately from the Neurotechnology products and thus, can´t be compared with the rest of the companies and Zimmer Biomet that publishes Spine and CMF results together.Also, Seaspine, RTI, Globus and Orthofix include biomaterials and Orthopediatrics incorporate Trauma sales.
- NUVASIVE
First Quarter 2019
NuVasive reported first quarter 2019 total revenue of $274.8 million, a 5.5% increase compared to $260.5 million for the first quarter 2018. On a constant currency basis, first quarter 2019 total revenue increased 6.4% compared to the same period last year. https://thespinemarketgroup.com/nuvasive-announces-first-quarter-2019-financial-results/
Second Quarter 2019
NuVasive reported second quarter 2019 total revenue of $292.1 million, a 3.7% increase compared to $281.6 million for the second quarter 2018. On a constant currency basis, second quarter 2019 total revenue increased 4.7% compared to the same period last year. https://thespinemarketgroup.com/nuvasive-announces-second-quarter-2019-financial-results/
Third Quarter 2019
NuVasive reported third quarter 2019 total revenue of $290.8 million, a 7.2% increase compared to $271.3 million for the third quarter 2018. On a constant currency basis, third quarter 2019 total revenue increased 7.5% compared to the same period last year. https://thespinemarketgroup.com/nuvasive-announces-third-quarter-2019-financial-results/
- JOHNSON&JOHNSON
First Quarter 2019
Total revenue for the first quarter of 2019 was $788 million, a -2,2% decrease compared to the same period of the prior year ($804 million).https://johnsonandjohnson.gcs-web.com/static-files/fa266c84-78d3-4efc-a296-bd2336c84087
Second Quarter 2019
Total revenue for the second quarter of 2019 was $818million, a -3,1% decrease compared to the same period of the prior year ($845 million). https://johnsonandjohnson.gcs-web.com/static-files/95ebb82c-8664-41a2-bfc1-c3d13a17eaeb
Third Quarter 2019
Total revenue for the third quarter of 2019 was $778 million, a -0,9% decrease compared to the same period of the prior year ($786 million). https://johnsonandjohnson.gcs-web.com/static-files/01c41b7f-9656-40ae-a7a9-445a2cc2304e
- SEASPINE
First Quarter 2019
Total revenue for the first quarter of 2019 was $36.2 million, a 9% increase compared to the same period of the prior year. Orthobiologics revenue totaled $19.0 million, a 6% increase compared to the first quarter of 2018. Spinal implants revenue totaled $17.1 million, a 13% increase compared to the first quarter of 2018. https://thespinemarketgroup.com/seaspine-reports-first-quarter-2019-financial-results/
Second Quarter 2019
Total revenue for the second quarter of 2019 was $39.3 million, an 8% increase compared to the same period of the prior year. Total U.S. revenue was $35.1 million, a 7.5% increase compared to the same period of the prior year. Orthobiologics revenue totaled $20.0 million, a 7.6% increase compared to the second quarter of 2018. Spinal implants revenue totaled $19.3 million, an 8.4% increase compared to the second quarter of 2018. https://thespinemarketgroup.com/seaspine-reports-second-quarter-2019-financial-results/
Third Quarter 2019
Revenue for the third quarter of 2019 was $39.9 million, an 11% increase compared to the same period of the prior year. Spinal Implants revenue was $19.8 million, a 15% increase compared to the same period of the prior year. The $2.5 million increase was driven by growth in recently launched products. Orthobiologics revenue was $20.1 million, an 8% increase compared to the same period of the prior year. The $1.5 million increase was driven by growth in recently launched products. https://thespinemarketgroup.com/seaspine-reports-record-revenue-driven-by-16-u-s-spinal-implants-growth/
- RTI Surgical
First Quarter 2019
RTI’s worldwide revenues for the first quarter of 2019 were $69.7 million, compared with $69.9 million during the same period in the prior year. https://thespinemarketgroup.com/rti-surgical-announces-first-quarter-2019-results/
Second Quarter 2019
Revenue of $82.3 million, up approximately 16% compared to the second quarter of 2018.https://thespinemarketgroup.com/rti-surgical-announces-second-quarter-2019-results/
Third Quarter 2019
RTI’s worldwide revenues for the third quarter of 2019 were $76.1 million, an increase of $7.1 million, or 10.2% compared with $69.1 million during the same period in the prior year. https://thespinemarketgroup.com/rti-surgical-announces-third-quarter-2019-results/
- GLOBUS MEDICAL
First Quarter 2019
Worldwide sales for the first quarter were $182.9 million, an increase of 4.9% over the first quarter of 2018 on an as-reported basis and 5.7% on a constant currency basis. First quarter sales in the U.S., including robotics, increased by 1.3% as quarterly seasonality and longer sales cycles dampened robotic sales compared to the first quarter of 2018. International sales increased by 23.0% over the first quarter of 2018 on an as-reported basis and 27.9% on a constant currency basis. https://thespinemarketgroup.com/globus-medical-reports-first-quarter-2019-results/
Second Quarter 2019
Worldwide sales for the second quarter were $194.5 million, an increase of 12.2% over the second quarter of 2018 on an as-reported basis and 12.7% on a constant currency basis. https://thespinemarketgroup.com/globus-medical-reports-second-quarter-2019-results/
Third Quarter 2019
Worldwide sales for the third quarter were $196.2 million, an increase of 15.9% over the third quarter of 2018 on an as-reported basis and 16.0% on a constant currency basis. https://thespinemarketgroup.com/globus-medical-reports-third-quarter-2019-results/
- ALPHATEC
First Quarter 2019
Revenue from U.S. products for the first quarter 2019 was $23.0 million, up 20% compared to $19.2 million in the first quarter 2018. https://thespinemarketgroup.com/alphatec-reports-first-quarter-2019-financial-results-and-corporate-highlights/
Second Quarter 2019
Total net revenue of $27.3 million; U.S. revenue of $26.1 million, up approximately 28% compared to the second quarter of 2018;https://thespinemarketgroup.com/alphatec-reports-second-quarter-2019-financial-results-and-corporate-highlights/
Third Quarter 2019
Total net revenue of $29.2 million; U.S. revenue of $28.1 million, up 34% compared to the prior year.https://thespinemarketgroup.com/atec-reports-third-quarter-2019-financial-results-and-recent-corporate-highlights/
- ORTHOFIX
First Quarter 2019
Global Spine sales of $85.9 million increased 5.8% in the quarter and 6.1% in constant currency. https://thespinemarketgroup.com/orthofix-reports-first-quarter-2019-results/
Second Quarter 2019
Global Spine sales of $90.079 million increased 3.8% in the quarter and 4.0% in constant currency. https://thespinemarketgroup.com/orthofix-reports-second-quarter-2019-results/
Third Quarter 2019
Global Spine sales of $88 million increased 3.9% in the quarter and 4% in constant currency. https://thespinemarketgroup.com/orthofix-reports-third-quarter-2019-results/
- MEDTRONIC
Medtronic 2019 fiscal year finished last July with the following sales reported :Medtronic-2019-Annual-ReportDownload
Spine during the 2019 fiscal year reported revenues of $2654 million increased 0.5% percent.
- STRYKER
First Quarter 2019
Neurotechnology and Spine net sales of $0.7 billion increased 20.7% in the quarter and 23.2% in constant currency. Organic net sales increased 7.8% in the quarter including 8.9% from increased unit volume partially offset by 1.1% from lower prices. https://thespinemarketgroup.com/stryker-reports-first-quarter-2019-operating-results/
Second Quarter 2019
Neurotechnology and Spine net sales of $0.8 billion increased 18.9% in the quarter and 20.8% in constant currency. Organic net sales increased 7.4% in the quarter including 8.7% from increased unit volume partially offset by 1.3% from lower prices. https://thespinemarketgroup.com/stryker-reports-second-quarter-2019-operating-results/
Third Quarter 2019
Neurotechnology and Spine net sales of $0.7 billion increased 19.4% in the quarter and 20.2% in constant currency. Organic net sales increased 7.6% in the quarter including 7.8% from increased unit volume partially offset by 0.2% from lower prices.https://thespinemarketgroup.com/stryker-reports-third-quarter-2019-operating-results/
- ZIMMER BIOMET
First Quarter 2019
Spine an CMF net sales of $183 million increased 0.1% in the quarter and 1.7% in constant currency. https://investor.zimmerbiomet.com/news-and-events/news/2019/04-26-2019-105943801
Second Quarter 2019
Spine an CMF net sales of $186 million increased 6.2% in the quarter and 4.9% in constant currency. https://www.prnewswire.com/news-releases/zimmer-biomet-announces-second-quarter-2019-financial-results-300891548.html
Third Quarter 2019
Spine an CMF net sales of $181 million decreased -1.9% in the quarter and -1.3% in constant currency. https://thespinemarketgroup.com/zimmer-biomet-announces-third-quarter-2019-financial-results/
- XTANT Medical
First Quarter 2019
First quarter 2019 revenue was $16.7 million, compared to $17.9 million for the same period in 2018. https://thespinemarketgroup.com/30073-2/
Second Quarter 2019
Second quarter 2019 revenue was $15.3 million, compared to $18.7 million for the same period in 2018. This decrease was due primarily to reduced demand for hardware products, which was due in part to effects from the December 2018 recall of the Calix Lumbar Spine Implant System, the termination of an advisory agreement with an entity that provided services to certain customers, and transition of independent sales agents. https://thespinemarketgroup.com/xtant-medical-announces-second-quarter-2019-financial-results/
Third Quarter 2019
Third quarter 2019 revenue was $15.7 million, compared to $17.3 million for the same period in 2018. This decrease was due primarily to reduced demand for hardware products, which was attributable in part to the termination of an advisory agreement with an entity that provided services to certain customers, and the continued transition of independent sales agents. Xtant Medical Announces Third Quarter 2019 Financial Results
- ORTHOPEDIATRICS
First Quarter 2019
Total revenue for the first quarter 2019 was $14.7 million, representing 21.2% growth, compared to total revenue of $12.1 million for the first quarter 2018. U.S. revenue for the first quarter of 2019 increased 18.7% to $10.3 million, compared to $8.7 million for the same period last year, and represented 70.1% of total revenue. International revenue increased 27.6% to $4.4 million, compared to $3.4 million for the same period last year and represented 29.9% of total revenue. Trauma and Deformity revenue for first quarter 2019 increased 9.8% to $10.0 million compared to $9.1 million for the same period last year. Scoliosis revenue increased 58.6% to $4.3 million compared to $2.7 million for the first quarter 2018. Sports Medicine/Other revenue for the first quarter of 2019 increased 33.2% to $0.4 million compared to $0.3 million for the same period last year. https://ir.orthopediatrics.com/static-files/81a627dd-2c95-4c37-93be-f8b1aaa26e63
Second Quarter 2019
Total revenue for the second quarter of 2019 was $18.2 million, including Orthex, a 20.7% increase compared to $15.1 million for the same period last year. U.S. revenue, including Orthex, for the second quarter of 2019 was $13.8 million, a 20.9% increase compared to $11.5 million for the same period last year, representing 76.1% of total revenue. International revenue, including Orthex, was $4.4 million, a 20.3% increase compared to $3.6 million for the same period last year, representing 23.9% of total revenue. Trauma and Deformity revenue for the second quarter of 2019 was $11.9 million, a 20.6% increase compared to $9.9 million for the same period last year. Scoliosis revenue was $5.9 million, a 19.8% increase compared to $4.9 million for the second quarter of 2018. Sports Medicine/Other revenue for the second quarter of 2019 was $0.4 million, a 39.7% increase compared to $0.3 million for the same period last year. http://ir.orthopediatrics.com/static-files/422e54fc-f9a7-4c71-ac93-9f69e8df781e
Third Quarter 2019
Total revenue for the third quarter of 2019 was $20.7 million, a 31.1% increase compared to $15.8 million for the same period last year. U.S. revenue for the third quarter of 2019 was $16.8 million, a 35.1% increase compared to $12.4 million for the same period last year, representing 80.9% of total revenue. International revenue was $4.0 million, a 16.5% increase compared to $3.4 million for the same period last year, representing 19.1% of total revenue. https://www.globenewswire.com/news-release/2019/11/07/1943616/0/en/OrthoPediatrics-Corp-Reports-Third-Quarter-2019-Financial-Results.html